CareDx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CareDx and other ETFs, options, and stocks.

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. 

CEO
John W. Hanna
CEOJohn W. Hanna
Employees
765
Employees765
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1998
Founded1998
Employees
765
Employees765

CDNA Key Statistics

Market cap
1.10B
Market cap1.10B
Price-Earnings ratio
-54.32
Price-Earnings ratio-54.32
Dividend yield
Dividend yield
Average volume
920.47K
Average volume920.47K
High today
$23.24
High today$23.24
Low today
$20.90
Low today$20.90
Open price
$22.81
Open price$22.81
Volume
1.39M
Volume1.39M
52 Week high
$23.24
52 Week high$23.24
52 Week low
$10.96
52 Week low$10.96

Stock Snapshot

CareDx(CDNA) stock is priced at $21.43, giving the company a market capitalization of 1.1B. It carries a P/E multiple of -54.32.

During the trading session on 2026-04-20, CareDx(CDNA) shares reached a daily high of $23.24 and a low of $20.90. At a current price of $21.43, the stock is +2.5% higher than the low and still -7.8% under the high.

Trading volume for CareDx(CDNA) stock has reached 1.39M, versus its average volume of 920.47K.

Over the past 52 weeks, CareDx(CDNA) stock has traded between a high of $23.24 and a low of $10.96.

Over the past 52 weeks, CareDx(CDNA) stock has traded between a high of $23.24 and a low of $10.96.

CDNA News

Benzinga 4d
CareDx Sharpens Focus On Core Testing Services

The transaction, approved by both companies' boards, is expected to close by the end of the third quarter of 2026. • CareDx stock is at critical resistance. Why...

CareDx Sharpens Focus On Core Testing Services
TipRanks 4d
CareDx Divests Lab Products to Refocus on Core Growth

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d
CareDx to divest Lab Products unit to EuroBio for $170M cash consideration

CareDx (CDNA) announced that it has entered into a definitive agreement to divest its Lab Products business to EuroBio Scientific for cash consideration of $170...

Analyst ratings

56%

of 9 ratings
Buy
44.4%
Hold
55.6%
Sell
0%

People also own

Based on the portfolios of people who own CDNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.